LFCR 8-K 2026-01-16

LIFECORE BIOMEDICAL, INC. DE (LFCR) 8-K dated 2026-01-16 — accession 0001628280-26-002400. This URL is the filing, not the LFCR hub.

LIFECORE BIOMEDICAL, INC. DE (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.

LIFECORE BIOMEDICAL, INC. DE filed a 8-K on 2026-01-16. Accession 0001628280-26-002400.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.

Not investment advice. The LFCR SEC hub lists recent forms. The stock page is the research view.